Experts Raise Questions about Current Standards of Drug Regulation
Surrogate endpoints provide no guarantee of clinical benefit and should be used only as a last resort in drug trials
Drug Development
How ELNs Can Help to Drive Innovation in Life Sciences
Electronic lab notebooks have the potential to significantly improve data management issues in biopharmaceutical development
Drug Researchers Tackle the Malaria Parasite at Multiple Life Stages
Researchers begin further testing of two inexpensive and effective antimalarial drug candidates
Transforming Biologic Drug Development
Making simultaneous CE-SDS/CIEF analyses of multiple samples possible
Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Scientists have found that the drug masitinib may be effective in treating COVID-19
Key Aspects of Regulatory Approval for New Drugs
In this Q&A, Francisco Polidoro, Junior, PhD, discusses the basics of the drug review and approval process, current challenges, and areas for improvement
Insights into the Main Stages of Pharmaceutical Discovery and Development
Key challenges and solutions at each stage of drug development
Streamline Organoid Procedures
Transfer, automated staining, and imaging of organoids
Microfluidics to Improve Complex Assay Performance
Improved assays with magnetically coated 3D cell models
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-Oncology Therapies
Expanded capabilities in company’s Immunogenicity and Immuno-oncology QSP Simulators broaden applicability for addressing safety and efficacy challenges